Asta expands senior management team with three key appointments

New hires strengthen underwriting, innovation, and client management

Asta expands senior management team with three key appointments

Insurance News

By Kenneth Araullo

Asta, the third-party managing agent at Lloyd's, has announced the addition of three senior management members to support its growing client base.

David Hopkins has been appointed deputy chief underwriting officer, Alex Poracchia has taken on the role of transformation director, and Julie Flello (pictured above) has been named head of client management.

Hopkins, who joined Asta last month, brings 27 years of experience in the financial services sector. He was previously head of underwriting performance management at Westfield Specialty and has held senior roles at Argo, Axis, and Antares.

His background in strategic decision-making and actuarial expertise will be key to his new role as deputy CUO.

Poracchia joined Asta in early July, having served as international insurance CFO and chief actuary at Everest for four years. His previous roles include global CFO at Zurich Financial Services and partner at Deloitte.

At Asta, Poracchia will work closely with the senior management team to drive innovation and support the company’s long-term growth.

Flello, who was appointed head of client management in April, brings 12 years of experience at Lloyd’s, where she held roles as survey and claims coordinator and senior account manager.

She has also served in employee engagement and DEI committee positions, and her 30 years of industry experience will be critical in managing Asta’s expanding client portfolio.

Asta’s CEO, Lorraine Harfitt, said the new appointments reflect the firm’s ongoing growth and commitment to attracting top talent.

She noted that Hopkins, Poracchia, and Flello bring a broad range of skills and experience that will be instrumental in supporting the company’s success and client service.

Earlier this year, the MGA announced that it has secured “in-principle” approval for its syndicate-in-a-box (SIAB) named MCI Syndicate 1966.

The development paves the way for a new insurance product aimed at expediting the progress of new therapeutic drugs. With the support of Lloyd’s consortia, MCI Syndicate 1966 is set to begin underwriting activities from April 2024, anticipating an annual gross premium of £75 million for the year, pending completion of Lloyd’s final approval procedures.

What are your thoughts on this story? Please feel free to share your comments below.

 

Related Stories

Keep up with the latest news and events

Join our mailing list, it’s free!